Terms: = Germ cell tumor AND KMT2A, TRX1, 4297, MLL, ENSG00000118058, MLL/GAS7, HTRX1, HRX, ALL-1, MLL1A, CXXC7 AND Treatment
31 results:
1. [Clinical analysis of 12 cases of ovarian yolk sac tumor].
Liu J; Chu HJ; Shan YP; Song WJ; Chen AP
Zhonghua Fu Chan Ke Za Zhi; 2024 Mar; 59(3):210-214. PubMed ID: 38544450
[No Abstract] [Full Text] [Related]
2. Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival.
Ozyerli-Goknar E; Kala EY; Aksu AC; Bulut I; Cingöz A; Nizamuddin S; Biniossek M; Seker-Polat F; Morova T; Aztekin C; Kung SHY; Syed H; Tuncbag N; Gönen M; Philpott M; Cribbs AP; Acilan C; Lack NA; Onder TT; Timmers HTM; Bagci-Onder T
Cell Commun Signal; 2023 Nov; 21(1):328. PubMed ID: 37974198
[TBL] [Abstract] [Full Text] [Related]
3. Nanoparticles Hitchhike on Monocytes for Glioblastoma treatment after Low-Dose Radiotherapy.
Kuang J; Rao ZY; Zheng DW; Kuang D; Huang QX; Pan T; Li H; Zeng X; Zhang XZ
ACS Nano; 2023 Jul; 17(14):13333-13347. PubMed ID: 37404077
[TBL] [Abstract] [Full Text] [Related]
4. Health-related quality of life and cognitive failures in patients with lower-grade gliomas treated with radiotherapy.
Di Perri D; Jmil S; Lawson TM; Van Calster L; Whenham N; Renard L
Cancer Radiother; 2023 May; 27(3):219-224. PubMed ID: 37080857
[TBL] [Abstract] [Full Text] [Related]
5. Downregulation of BASP1 Promotes Temozolomide Resistance in Gliomas via Epigenetic Activation of the FBXO32/NF-κB/MGMT Axis.
Liao X; Li Z; Zheng H; Qian W; Zhang S; Chen S; Li X; Tang M; Xu Y; Yu R; Li M; Song L; Li J
Mol Cancer Res; 2023 Jul; 21(7):648-663. PubMed ID: 36961398
[TBL] [Abstract] [Full Text] [Related]
6. A secondary CD34+ acute lymphoblastic leukemia unmasked and mobilized by G-CSF in an autologous stem cell donor with testicular cancer.
Cooling L; Kelley J; Sexton E; Anand S; Hoffmann S
Transfusion; 2023 Apr; 63(4):684-689. PubMed ID: 36762622
[TBL] [Abstract] [Full Text] [Related]
7. Diallyl trisulfide sensitizes radiation therapy on glioblastoma through directly targeting thioredoxin 1.
Tian Y; Ge Z; Xu M; Ge X; Zhao M; Ding F; Yin J; Wang X; You Y; Shi Z; Qian X
Free Radic Biol Med; 2022 Aug; 189():157-168. PubMed ID: 35921994
[TBL] [Abstract] [Full Text] [Related]
8. Sex Differences in Cutaneous Melanoma: Incidence, Clinicopathological Profile, Survival, and Costs.
Buja A; Rugge M; Damiani G; Zorzi M; De Toni C; Vecchiato A; Del Fiore P; Spina R; Baldo V; Brazzale AR; Rossi CR; Mocellin S
J Womens Health (Larchmt); 2022 Jul; 31(7):1012-1019. PubMed ID: 35076310
[No Abstract] [Full Text] [Related]
9. Brg1 mutation alters oxidative stress responses in glioblastoma.
Gowda P; Lathoria K; Umdor SB; Sen E
Neurochem Int; 2021 Nov; 150():105189. PubMed ID: 34543701
[TBL] [Abstract] [Full Text] [Related]
10. Alcohol-abuse drug disulfiram targets pediatric glioma via mll degradation.
Meier S; Cantilena S; Niklison Chirou MV; Anderson J; Hargrave D; Salomoni P; de Boer J; Michod D
Cell Death Dis; 2021 Aug; 12(8):785. PubMed ID: 34381018
[TBL] [Abstract] [Full Text] [Related]
11. Brain-derived neurotrophic factor induces thioredoxin-1 expression through TrkB/Akt/CREB pathway in SH-SY5Y cells.
Bai L; Zhang S; Zhou X; Li Y; Bai J
Biochimie; 2019 May; 160():55-60. PubMed ID: 30796965
[TBL] [Abstract] [Full Text] [Related]
12. Quality of Life Within the First 6 Months of Vestibular Schwannoma Diagnosis With Implications for Patient Counseling.
Carlson ML; Tombers NM; Kerezoudis P; Celda MP; Lohse CM; Link MJ
Otol Neurotol; 2018 Dec; 39(10):e1129-e1136. PubMed ID: 30239440
[TBL] [Abstract] [Full Text] [Related]
13. Correlation between early 18F-FDG PET/CT response to BRAF and MEK inhibition and survival in patients with BRAF-mutant metastatic melanoma.
Schmitt RJ; Kreidler SM; Glueck DH; Amaria RN; Gonzalez R; Lewis K; Bagrosky BM; Kwak JJ; Koo PJ
Nucl Med Commun; 2016 Feb; 37(2):122-8. PubMed ID: 26440571
[TBL] [Abstract] [Full Text] [Related]
14. TGF-β-induced hCG-β regulates redox homeostasis in glioma cells.
Ahmad F; Ghosh S; Sinha S; Joshi SD; Mehta VS; Sen E
Mol Cell Biochem; 2015 Jan; 399(1-2):105-12. PubMed ID: 25300619
[TBL] [Abstract] [Full Text] [Related]
15. Mesenteric lymphatic ligation in the prevention of chylous fistulae in abdominal neuroblastoma surgery.
Chui CH
Pediatr Surg Int; 2014 Oct; 30(10):1009-12. PubMed ID: 25098440
[TBL] [Abstract] [Full Text] [Related]
16. The cost-effectiveness of temozolomide in the adjuvant treatment of newly diagnosed glioblastoma in the United States.
Messali A; Hay JW; Villacorta R
Neuro Oncol; 2013 Nov; 15(11):1532-42. PubMed ID: 23935155
[TBL] [Abstract] [Full Text] [Related]
17. Effect of the timing of orchiectomy on survival in patients with metastatic germ cell tumors of testis.
Fedyanin M; Tryakin A; Bulanov A; Fainshtein I; Zakharova T; Matveev V; Garin A; Tjulandin S
Urol Oncol; 2014 Jan; 32(1):32.e27-33. PubMed ID: 23628310
[TBL] [Abstract] [Full Text] [Related]
18. Long-term results of the randomized phase III trial EORTC 18991 of adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma.
Eggermont AM; Suciu S; Testori A; Santinami M; Kruit WH; Marsden J; Punt CJ; Salès F; Dummer R; Robert C; Schadendorf D; Patel PM; de Schaetzen G; Spatz A; Keilholz U
J Clin Oncol; 2012 Nov; 30(31):3810-8. PubMed ID: 23008300
[TBL] [Abstract] [Full Text] [Related]
19. p38(MAPK) and ERK1/2 dictate cell death/survival response to different pro-oxidant stimuli via p53 and Nrf2 in neuroblastoma cells SH-SY5Y.
Filomeni G; Piccirillo S; Rotilio G; Ciriolo MR
Biochem Pharmacol; 2012 May; 83(10):1349-57. PubMed ID: 22342995
[TBL] [Abstract] [Full Text] [Related]
20. Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma.
Kramer K; Kushner BH; Modak S; Pandit-Taskar N; Smith-Jones P; Zanzonico P; Humm JL; Xu H; Wolden SL; Souweidane MM; Larson SM; Cheung NK
J Neurooncol; 2010 May; 97(3):409-18. PubMed ID: 19890606
[TBL] [Abstract] [Full Text] [Related]
[Next]
